Results for staph infection translation from Danish to Spanish

patients deemed at risk of infection
at risk of infection

treatment of adenovirus infection in immunocompromised patients
treatment of adenovirus infection in immunocompromised patients

treatment of diarrhoea associated with intestinal microsporidial infection
treatment of diarrhoea associated with intestinal microsporidial infection

imidlertid kunne intracellulært drab af staph. aureus ikke påvises.
se ha demostrado la acumulación de la pirlimicina en células polimorfonucleares; sin embargo, no se ha podido demostrar la destrucción intracelular del staphylococcus aureus.

a) cattle b) adjunctive therapy in acute respiratory infection
a) solución inyectable

treatment of pseudomonas aeruginosa lung infection (including colonisation) in cystic
treatment of pseudomonas aeruginosa lung infection (including colonisation) in cystic fibrosis

j07ca immunisation against haemophilus influenzae type b and infection by hepatitis b virus in infants
j07ca immunisation against haemophilus influenzae type b and infection by hepatitis b virus in infants

active immunisation against hepatitis b virus infection caused by all known subtypes in children and adolescents
active immunisation against hepatitis b virus infection caused by all known subtypes in children and adolescents

single- dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women:
single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women:

escherichia coli j5: > 50 red60 * staph. aureus (cp8): > 50 red80 **
escherichia coli j5: > 50 red60 * staph. aureus (cp8): > 50 red80 **

titel på dokumentet points to consider on the clinical development of fibrinolytic medicinal products in the treatment of patients with st segment elevation acute myocardial infarction (stemi) note for guidance on the clinical development of medicinal products for the treatment of hiv infection.
título del documento points to consider on the clinical development of fibrinolytic medicinal products in the treatment of patients with st segment elevation acute myocardial infarction (stemi) note for guidance on the clinical development of medicinal products for the treatment of hiv infection.

eu/ 2/ 08/ 092/ 002 startvac escherichia coli j5: > 50 red60 * staph. aureus (cp8): > 50 red80 **
eu/ 2/ 08/ 092/ 002 startvac escherichia coli j5: > 50 red60 * staph. aureus (cp8): > 50 red80 **